AW
MRNA icon

Avion Wealth’s Moderna MRNA Stock Holding History

Avion Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35K Buy
186
+15
+9% +$1.62K 0.01% 290
2026
Q2 		$11K Sell
171
-18
-10% -$931 ﹤0.01% 577
2026
Q1 		$9K Buy
189
+53
+39% +$2.47K ﹤0.01% 522
2025
Q4 		$4K Buy
136
+80
+143% +$2.17K ﹤0.01% 713
2025
Q3 		$1K Sell
56
-75
-57% -$2.09K ﹤0.01% 1058
2025
Q2 		$3K Buy
131
+119
+992% +$3.13K ﹤0.01% 732
2025
Q1 		$0 Buy
+12
New +$426 ﹤0.01% 1236
2024
Q4 		– Sell
-31
Closed -$2K – 1180
2024
Q3 		$2K Sell
31
-23
-43% -$2.11K ﹤0.01% 701
2024
Q2 		$6K Sell
54
-20
-27% -$2.53K ﹤0.01% 435
2024
Q1 		$8K Buy
74
+8
+12% +$806 ﹤0.01% 357
2023
Q4 		$7K Buy
66
+37
+128% +$3.11K ﹤0.01% 333
2023
Q3 		$2K Buy
29
+25
+625% +$2.79K ﹤0.01% 502
2023
Q2 		$0 Buy
+4
New +$534 ﹤0.01% 929

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

Avion Wealth's MRNA Position: Q3 2026 in Review

Avion Wealth increased its Moderna (MRNA) stake by 8.8% in Q3 2026, buying an estimated $1.62K and bringing the position to 186 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #290.

Avion Wealth first reported a position in MRNA in Q2 2023 and has held it in 13 quarters since. 633 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Avion Wealth held 186 shares of Moderna worth $35K as of Q3 2026.
  • Avion Wealth bought 15 Moderna shares in Q3 2026, an estimated $1.62K.
  • Moderna made up 0.01% of Avion Wealth's portfolio in Q3 2026, its #290 holding.
  • Avion Wealth first reported a position in Moderna in Q2 2023 and has held it in 13 quarters since.
  • 633 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.